IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446
Authors Jin F, Miao Y, Xu P, Qiu X
Received 6 January 2018
Accepted for publication 25 June 2018
Published 11 September 2018 Volume 2018:11 Pages 5723—5731
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Geoffrey Pietersz
Fang Jin,1,2,* Yajing Miao,3,* Pengyu Xu,1 Xiaofei Qiu1
1Department of Pathology, Tianjin Medical University, Tianjin, China; 2Respiratory Department, Tianjin Medical University General Hospital, Tianjin, China; 3Research Center for Basic Medical Science, Tianjin Medical University, Tianjin, China
*These authors contributed equally to this work
Purpose: Cancer stem cells (CSCs) are a small population of cancer cells located within a tumor that are highly tumorigenic, capable of tumor initiation, and resistant to cancer therapies. We identified the potential genes involved in regulating stemness properties and investigated the mechanisms in small-cell lung cancer (SCLC).
Materials and methods: Whole transcriptome sequencing technology was used to screen the potential genes involved in regulating stemness properties from SCLC-SCs (uPAR+) and differentiated cells (uPAR-) in the H446 cell line. The selected genes were validated by quantitative reverse transcription PCR and ELISAs. The effect of IL-8 on stemness of sphere-forming cells was determined through tumor sphere formation, wound healing migration, and in vivo tumorigenesis assays.
Results: In our study, uPAR+ and uPAR- cells showed different gene expression profiles. IL-8 was upregulated in SCLC sphere-forming cells. Blocking IL-8 expression with siRNA led to loss of stemness, including the self-renewal capability, migration, expression of stemness-related genes, and in vivo tumorigenicity, in sphere-forming cells. Consistently, exogenously added IL-8 enhanced stemness properties in parental cells.
Conclusion: IL-8 was upregulated in SCLC sphere-forming cells, and critical for the acquisition and/or maintenance of the stemness features in the SCLC cell line H446. Our results suggest that blocking IL-8 signaling may provide a novel therapeutic approach for targeting SCLC-SCs and improve treatment and outcomes in SCLC.
Keywords: small-cell lung cancer, cancer stem cells, tumor sphere, IL-8, uPAR, stemness
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]